高级检索
当前位置: 首页 > 详情页

Inflammatory cytokine-induced expression of MASTL is involved in hepatocarcinogenesis by regulating cell cycle progression

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Hebei Univ, Affiliated Hosp, Dept Surg, 212 Yuhua East Rd, Baoding 071000, Hebei, Peoples R China [2]Hebei Univ, Coll Med, Baoding 071000, Hebei, Peoples R China [3]Jinan Univ, Zhuhai Hosp, Zhuhai Peoples Hosp, Dept Ultrasound Imaging, Zhuhai 519000, Guangdong, Peoples R China [4]Tianjin Med Univ, Coll Med, Tianjin 300070, Peoples R China
出处:
ISSN:

关键词: microtubule associated serine/threonine kinase-like inflammatory cytokines hepatocarcinogenesis mitosis

摘要:
Microtubule associated serine/threonine kinase-like (MASTL) is the functional mammalian ortholog of Greatwall kinase (Gwl), which was originally discovered in Drosophila. Gwl is an essential kinase for accurate chromosome condensation and mitotic progression, and inhibits protein phosphatase 2A (PP2A), which subsequently dephosphorylates the substrates of cyclin B1-cyclin-dependent kinase 1, leading to mitotic exit. Previous studies have indicated that MASTL has a critical function in the regulation of mitosis in HeLa and U2OS cell lines, though there is currently limited evidence for the involvement of MASTL in hepatocarcinogenesis. The results of the present study revealed that MASTL was inducible by the proinflammatory cytokines interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-alpha), which promoted the proliferation and mitotic entry of human liver cancer cells. It was also determined that MASTL was significantly overexpressed in cancerous liver tissues compared with non-tumor liver tissues. Mechanistically, stimulation by IL-6 and TNF-alpha induced the trimethylation of histone H3 lysine 4 (H3K4Me3) at the MASTL promoter to facilitate chromatin accessibility. Additionally, H3K4Me3 was associated with the activation of nuclear factor-kappa B, which subsequently upregulated MASTL expression. These findings suggested that MASTL may have pivotal functions in the development of hepatocarcinoma, and that it may be a potential target for treatment.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学
JCR分区:
出版当年[2019]版:
Q3 ONCOLOGY
最新[2023]版:
Q3 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者机构: [1]Hebei Univ, Affiliated Hosp, Dept Surg, 212 Yuhua East Rd, Baoding 071000, Hebei, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Hebei Univ, Affiliated Hosp, Dept Surg, 212 Yuhua East Rd, Baoding 071000, Hebei, Peoples R China [*1]Department of Surgery, The Affiliated Hospital of HebeiUniversity, 212 Yuhua East Road, Baoding, Hebei 071000, P.R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:15100 今日访问量:0 总访问量:960 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北大学附属医院 技术支持:重庆聚合科技有限公司 地址:保定市莲池区裕华东路212号